nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC22A2—Cytarabine—lymphatic system cancer	0.249	0.287	CbGbCtD
Chlorphenamine—SLC22A1—Cytarabine—lymphatic system cancer	0.217	0.249	CbGbCtD
Chlorphenamine—CYP3A5—Teniposide—lymphatic system cancer	0.1	0.116	CbGbCtD
Chlorphenamine—CYP3A7—Vincristine—lymphatic system cancer	0.0644	0.0742	CbGbCtD
Chlorphenamine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0644	0.0742	CbGbCtD
Chlorphenamine—CYP3A5—Vincristine—lymphatic system cancer	0.0483	0.0556	CbGbCtD
Chlorphenamine—CYP3A4—Cytarabine—lymphatic system cancer	0.0398	0.0458	CbGbCtD
Chlorphenamine—CYP3A4—Teniposide—lymphatic system cancer	0.0392	0.0451	CbGbCtD
Chlorphenamine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0274	0.0315	CbGbCtD
Chlorphenamine—CYP3A4—Vincristine—lymphatic system cancer	0.0188	0.0217	CbGbCtD
Chlorphenamine—Urinary hesitation—Fludarabine—lymphatic system cancer	0.00669	0.0509	CcSEcCtD
Chlorphenamine—Hyporeflexia—Vincristine—lymphatic system cancer	0.00369	0.0281	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.00341	0.0259	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.00251	0.0191	CcSEcCtD
Chlorphenamine—Neuritis—Vincristine—lymphatic system cancer	0.00225	0.0171	CcSEcCtD
Chlorphenamine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00221	0.0168	CcSEcCtD
Chlorphenamine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00198	0.0151	CcSEcCtD
Chlorphenamine—Wheezing—Bleomycin—lymphatic system cancer	0.00195	0.0149	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00171	0.013	CcSEcCtD
Chlorphenamine—Sweating increased—Fludarabine—lymphatic system cancer	0.00168	0.0128	CcSEcCtD
Chlorphenamine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00166	0.0127	CcSEcCtD
Chlorphenamine—Mental disability—Carmustine—lymphatic system cancer	0.00152	0.0116	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00151	0.0115	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00148	0.0113	CcSEcCtD
Chlorphenamine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00144	0.011	CcSEcCtD
Chlorphenamine—Chills—Teniposide—lymphatic system cancer	0.00141	0.0107	CcSEcCtD
Chlorphenamine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00131	0.01	CcSEcCtD
Chlorphenamine—Diplopia—Carmustine—lymphatic system cancer	0.00128	0.00971	CcSEcCtD
Chlorphenamine—Agitation—Teniposide—lymphatic system cancer	0.00125	0.00955	CcSEcCtD
Chlorphenamine—Chills—Fludarabine—lymphatic system cancer	0.00124	0.00941	CcSEcCtD
Chlorphenamine—Hypertension—Teniposide—lymphatic system cancer	0.00118	0.00897	CcSEcCtD
Chlorphenamine—Urinary retention—Vincristine—lymphatic system cancer	0.00116	0.00881	CcSEcCtD
Chlorphenamine—Confusional state—Teniposide—lymphatic system cancer	0.00112	0.00855	CcSEcCtD
Chlorphenamine—Agitation—Fludarabine—lymphatic system cancer	0.0011	0.00839	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00109	0.0083	CcSEcCtD
Chlorphenamine—Tachycardia—Teniposide—lymphatic system cancer	0.00109	0.00828	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00108	0.0082	CcSEcCtD
Chlorphenamine—Anorexia—Teniposide—lymphatic system cancer	0.00106	0.00808	CcSEcCtD
Chlorphenamine—Hypotension—Teniposide—lymphatic system cancer	0.00104	0.00792	CcSEcCtD
Chlorphenamine—Convulsion—Fludarabine—lymphatic system cancer	0.00104	0.00791	CcSEcCtD
Chlorphenamine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00103	0.00787	CcSEcCtD
Chlorphenamine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.000998	0.0076	CcSEcCtD
Chlorphenamine—Confusional state—Fludarabine—lymphatic system cancer	0.000987	0.00751	CcSEcCtD
Chlorphenamine—Decreased appetite—Teniposide—lymphatic system cancer	0.000969	0.00737	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000963	0.00733	CcSEcCtD
Chlorphenamine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000961	0.00731	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00096	0.00731	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000959	0.0073	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000947	0.0072	CcSEcCtD
Chlorphenamine—Anorexia—Fludarabine—lymphatic system cancer	0.000933	0.0071	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000919	0.007	CcSEcCtD
Chlorphenamine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000918	0.00699	CcSEcCtD
Chlorphenamine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000914	0.00695	CcSEcCtD
Chlorphenamine—Chills—Bleomycin—lymphatic system cancer	0.000907	0.0069	CcSEcCtD
Chlorphenamine—Nausea—Mechlorethamine—lymphatic system cancer	0.000898	0.00683	CcSEcCtD
Chlorphenamine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000879	0.00669	CcSEcCtD
Chlorphenamine—Hallucination—Carmustine—lymphatic system cancer	0.000878	0.00668	CcSEcCtD
Chlorphenamine—Dyspepsia—Fludarabine—lymphatic system cancer	0.000862	0.00656	CcSEcCtD
Chlorphenamine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000853	0.00649	CcSEcCtD
Chlorphenamine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000851	0.00648	CcSEcCtD
Chlorphenamine—Fatigue—Fludarabine—lymphatic system cancer	0.000844	0.00643	CcSEcCtD
Chlorphenamine—Hallucination—Vincristine—lymphatic system cancer	0.000838	0.00638	CcSEcCtD
Chlorphenamine—Constipation—Fludarabine—lymphatic system cancer	0.000837	0.00637	CcSEcCtD
Chlorphenamine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000807	0.00614	CcSEcCtD
Chlorphenamine—Asthenia—Teniposide—lymphatic system cancer	0.000799	0.00608	CcSEcCtD
Chlorphenamine—Diarrhoea—Teniposide—lymphatic system cancer	0.000762	0.0058	CcSEcCtD
Chlorphenamine—Chills—Mitoxantrone—lymphatic system cancer	0.000736	0.0056	CcSEcCtD
Chlorphenamine—Confusional state—Bleomycin—lymphatic system cancer	0.000724	0.00551	CcSEcCtD
Chlorphenamine—Vision blurred—Carmustine—lymphatic system cancer	0.000724	0.00551	CcSEcCtD
Chlorphenamine—Tremor—Carmustine—lymphatic system cancer	0.000719	0.00548	CcSEcCtD
Chlorphenamine—Vomiting—Teniposide—lymphatic system cancer	0.000708	0.00539	CcSEcCtD
Chlorphenamine—Agitation—Carmustine—lymphatic system cancer	0.000706	0.00537	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000703	0.00535	CcSEcCtD
Chlorphenamine—Asthenia—Fludarabine—lymphatic system cancer	0.000703	0.00535	CcSEcCtD
Chlorphenamine—Headache—Teniposide—lymphatic system cancer	0.000698	0.00531	CcSEcCtD
Chlorphenamine—Anorexia—Bleomycin—lymphatic system cancer	0.000684	0.00521	CcSEcCtD
Chlorphenamine—Agitation—Vincristine—lymphatic system cancer	0.000674	0.00513	CcSEcCtD
Chlorphenamine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000673	0.00512	CcSEcCtD
Chlorphenamine—Photosensitivity—Methotrexate—lymphatic system cancer	0.000673	0.00512	CcSEcCtD
Chlorphenamine—Hypotension—Bleomycin—lymphatic system cancer	0.000671	0.00511	CcSEcCtD
Chlorphenamine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00067	0.0051	CcSEcCtD
Chlorphenamine—Convulsion—Carmustine—lymphatic system cancer	0.000665	0.00506	CcSEcCtD
Chlorphenamine—Hypertension—Carmustine—lymphatic system cancer	0.000663	0.00505	CcSEcCtD
Chlorphenamine—Nausea—Teniposide—lymphatic system cancer	0.000662	0.00504	CcSEcCtD
Chlorphenamine—Vertigo—Vincristine—lymphatic system cancer	0.000659	0.00501	CcSEcCtD
Chlorphenamine—Anxiety—Carmustine—lymphatic system cancer	0.000652	0.00496	CcSEcCtD
Chlorphenamine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000645	0.00491	CcSEcCtD
Chlorphenamine—Convulsion—Vincristine—lymphatic system cancer	0.000635	0.00483	CcSEcCtD
Chlorphenamine—Hypertension—Vincristine—lymphatic system cancer	0.000633	0.00482	CcSEcCtD
Chlorphenamine—Confusional state—Carmustine—lymphatic system cancer	0.000632	0.00481	CcSEcCtD
Chlorphenamine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000624	0.00475	CcSEcCtD
Chlorphenamine—Vomiting—Fludarabine—lymphatic system cancer	0.000623	0.00474	CcSEcCtD
Chlorphenamine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000619	0.00471	CcSEcCtD
Chlorphenamine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000616	0.00469	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000614	0.00467	CcSEcCtD
Chlorphenamine—Headache—Fludarabine—lymphatic system cancer	0.000613	0.00467	CcSEcCtD
Chlorphenamine—Tachycardia—Carmustine—lymphatic system cancer	0.000612	0.00466	CcSEcCtD
Chlorphenamine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000606	0.00461	CcSEcCtD
Chlorphenamine—Anorexia—Carmustine—lymphatic system cancer	0.000597	0.00455	CcSEcCtD
Chlorphenamine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000592	0.0045	CcSEcCtD
Chlorphenamine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000587	0.00447	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000586	0.00446	CcSEcCtD
Chlorphenamine—Hypotension—Carmustine—lymphatic system cancer	0.000586	0.00446	CcSEcCtD
Chlorphenamine—Nausea—Fludarabine—lymphatic system cancer	0.000582	0.00443	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000578	0.0044	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00057	0.00434	CcSEcCtD
Chlorphenamine—Anorexia—Vincristine—lymphatic system cancer	0.00057	0.00434	CcSEcCtD
Chlorphenamine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000569	0.00433	CcSEcCtD
Chlorphenamine—Insomnia—Carmustine—lymphatic system cancer	0.000567	0.00431	CcSEcCtD
Chlorphenamine—Irritability—Methotrexate—lymphatic system cancer	0.000564	0.00429	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000563	0.00429	CcSEcCtD
Chlorphenamine—Paraesthesia—Carmustine—lymphatic system cancer	0.000563	0.00428	CcSEcCtD
Chlorphenamine—Hypotension—Vincristine—lymphatic system cancer	0.000559	0.00425	CcSEcCtD
Chlorphenamine—Somnolence—Carmustine—lymphatic system cancer	0.000557	0.00424	CcSEcCtD
Chlorphenamine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000555	0.00423	CcSEcCtD
Chlorphenamine—Decreased appetite—Carmustine—lymphatic system cancer	0.000545	0.00415	CcSEcCtD
Chlorphenamine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000544	0.00414	CcSEcCtD
Chlorphenamine—Insomnia—Vincristine—lymphatic system cancer	0.000541	0.00412	CcSEcCtD
Chlorphenamine—Paraesthesia—Vincristine—lymphatic system cancer	0.000537	0.00409	CcSEcCtD
Chlorphenamine—Constipation—Carmustine—lymphatic system cancer	0.000536	0.00408	CcSEcCtD
Chlorphenamine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000523	0.00398	CcSEcCtD
Chlorphenamine—Decreased appetite—Vincristine—lymphatic system cancer	0.00052	0.00396	CcSEcCtD
Chlorphenamine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000518	0.00394	CcSEcCtD
Chlorphenamine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000516	0.00393	CcSEcCtD
Chlorphenamine—Fatigue—Vincristine—lymphatic system cancer	0.000516	0.00393	CcSEcCtD
Chlorphenamine—Asthenia—Bleomycin—lymphatic system cancer	0.000515	0.00392	CcSEcCtD
Chlorphenamine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000513	0.0039	CcSEcCtD
Chlorphenamine—Constipation—Vincristine—lymphatic system cancer	0.000512	0.00389	CcSEcCtD
Chlorphenamine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000506	0.00385	CcSEcCtD
Chlorphenamine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000502	0.00382	CcSEcCtD
Chlorphenamine—Constipation—Mitoxantrone—lymphatic system cancer	0.000498	0.00379	CcSEcCtD
Chlorphenamine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00048	0.00365	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000466	0.00355	CcSEcCtD
Chlorphenamine—Vomiting—Bleomycin—lymphatic system cancer	0.000457	0.00347	CcSEcCtD
Chlorphenamine—Drowsiness—Methotrexate—lymphatic system cancer	0.000455	0.00346	CcSEcCtD
Chlorphenamine—Asthenia—Carmustine—lymphatic system cancer	0.00045	0.00342	CcSEcCtD
Chlorphenamine—Asthenia—Vincristine—lymphatic system cancer	0.000429	0.00327	CcSEcCtD
Chlorphenamine—Diarrhoea—Carmustine—lymphatic system cancer	0.000429	0.00326	CcSEcCtD
Chlorphenamine—Nausea—Bleomycin—lymphatic system cancer	0.000426	0.00325	CcSEcCtD
Chlorphenamine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000425	0.00323	CcSEcCtD
Chlorphenamine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000418	0.00318	CcSEcCtD
Chlorphenamine—Dizziness—Carmustine—lymphatic system cancer	0.000414	0.00315	CcSEcCtD
Chlorphenamine—Diarrhoea—Vincristine—lymphatic system cancer	0.000409	0.00312	CcSEcCtD
Chlorphenamine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000399	0.00303	CcSEcCtD
Chlorphenamine—Vomiting—Carmustine—lymphatic system cancer	0.000398	0.00303	CcSEcCtD
Chlorphenamine—Dizziness—Vincristine—lymphatic system cancer	0.000396	0.00301	CcSEcCtD
Chlorphenamine—Headache—Carmustine—lymphatic system cancer	0.000393	0.00299	CcSEcCtD
Chlorphenamine—Tinnitus—Methotrexate—lymphatic system cancer	0.000381	0.0029	CcSEcCtD
Chlorphenamine—Vomiting—Vincristine—lymphatic system cancer	0.00038	0.0029	CcSEcCtD
Chlorphenamine—Headache—Vincristine—lymphatic system cancer	0.000375	0.00285	CcSEcCtD
Chlorphenamine—Nausea—Carmustine—lymphatic system cancer	0.000372	0.00283	CcSEcCtD
Chlorphenamine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00037	0.00282	CcSEcCtD
Chlorphenamine—Chills—Methotrexate—lymphatic system cancer	0.000367	0.00279	CcSEcCtD
Chlorphenamine—Headache—Mitoxantrone—lymphatic system cancer	0.000365	0.00278	CcSEcCtD
Chlorphenamine—Nausea—Vincristine—lymphatic system cancer	0.000355	0.0027	CcSEcCtD
Chlorphenamine—Nausea—Mitoxantrone—lymphatic system cancer	0.000346	0.00263	CcSEcCtD
Chlorphenamine—Vision blurred—Methotrexate—lymphatic system cancer	0.000335	0.00255	CcSEcCtD
Chlorphenamine—Vertigo—Methotrexate—lymphatic system cancer	0.00032	0.00243	CcSEcCtD
Chlorphenamine—Convulsion—Methotrexate—lymphatic system cancer	0.000308	0.00235	CcSEcCtD
Chlorphenamine—Confusional state—Methotrexate—lymphatic system cancer	0.000293	0.00223	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000284	0.00216	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000281	0.00214	CcSEcCtD
Chlorphenamine—Anorexia—Methotrexate—lymphatic system cancer	0.000277	0.00211	CcSEcCtD
Chlorphenamine—Hypotension—Methotrexate—lymphatic system cancer	0.000271	0.00206	CcSEcCtD
Chlorphenamine—Insomnia—Methotrexate—lymphatic system cancer	0.000263	0.002	CcSEcCtD
Chlorphenamine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000261	0.00198	CcSEcCtD
Chlorphenamine—Somnolence—Methotrexate—lymphatic system cancer	0.000258	0.00196	CcSEcCtD
Chlorphenamine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000256	0.00194	CcSEcCtD
Chlorphenamine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000252	0.00192	CcSEcCtD
Chlorphenamine—Fatigue—Methotrexate—lymphatic system cancer	0.00025	0.0019	CcSEcCtD
Chlorphenamine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000239	0.00182	CcSEcCtD
Chlorphenamine—Asthenia—Methotrexate—lymphatic system cancer	0.000208	0.00159	CcSEcCtD
Chlorphenamine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000199	0.00151	CcSEcCtD
Chlorphenamine—Dizziness—Methotrexate—lymphatic system cancer	0.000192	0.00146	CcSEcCtD
Chlorphenamine—Vomiting—Methotrexate—lymphatic system cancer	0.000185	0.0014	CcSEcCtD
Chlorphenamine—Headache—Methotrexate—lymphatic system cancer	0.000182	0.00138	CcSEcCtD
Chlorphenamine—Nausea—Methotrexate—lymphatic system cancer	0.000172	0.00131	CcSEcCtD
